Skip to main content
Clinical Trials/NCT05121090
NCT05121090
Active, not recruiting
Not Applicable

Prevention of Child Obesity: an Interventional Study of a Personalized Multidisciplinary Care Efficacy in Children of Primary School

University Hospital, Lille2 sites in 1 country460 target enrollmentJanuary 19, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight, Infant
Sponsor
University Hospital, Lille
Enrollment
460
Locations
2
Primary Endpoint
Changes in BMI Z-score
Status
Active, not recruiting
Last Updated
10 days ago

Overview

Brief Summary

Obesity could be avoided but once declared it become a chronic disease with numerous health complications, including cardiovascular and metabolic diseases, cancers, and finally a loss of life expectancy. Considering that after the age of 6 years old, half of the obese children will become obese adults, the WHO has been declared childhood obesity prevention as a health priority area. Large-scale prevention of obesity is challenging and it would be more efficient to proceed to early identification of high risks children to implement personalized prevention.

The ELIPSE study main objective is to evaluate the efficacy of personalized multidisciplinary care to reduce the BMI of overweight or obese children. A 2 years educational program will be evaluated at short and longer terms (after a 12 months follow-up), and its benefits will also be assessed based on comparison with a historical control group.

Along with efficacy evaluation, scientific objectives were designed to investigate clinical, genetic, social, and behavioural risk factors and to analyse potential correlations between these factors and a predisposition to overweight or obesity. Moreover, advanced analyses will be performed to decipher the impact of diverse risk profiles on the efficacy of the educational program.

The motive of the ELIPSE study is to promote the health and well-being of children and their families to tackle the health burden represented by childhood overweight and obesity. Combined with innovative scientific objectives, this study ambitions to develop more efficient and more personalized preventive care methods.

Registry
clinicaltrials.gov
Start Date
January 19, 2022
End Date
April 1, 2027
Last Updated
10 days ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Lille
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children from the first year of primary school in Lille City
  • Overweight or obese children as defined by the IOTF and/or with at least one of the following risk factors: 1) early adiposity rebound (before 6 years old), 2) an upward crossing of major percentiles on the BMI curve (after 6 years old).
  • Children whose legal tutor(s) is(are) able to understand the enlightened information.
  • Children whose legal tutor(s) has(ve) signed the free and informed consent.

Exclusion Criteria

  • Refusal from children or their tutors to participate in the study.
  • Impossibility to participate in the study in its totality.
  • Pathology known to impact the BMI: follow-up care for eating behaviour problems, endocrine disorders (hypercorticism, hypothyroidism, growth factor deficiency, hypothalamic-hypophysis lesions), genetic disorders (Prader Willi syndrome, Bardet-Biedl syndrome), drugs that affect body weight (antidepressant, neuroleptics, corticoids).
  • Previous participation in a similar educational program.

Outcomes

Primary Outcomes

Changes in BMI Z-score

Time Frame: At the end of the educational program, an average of 2 years after inclusion

The objective is to estimate the mean variation of the BMI Z-score between the inclusion and the end of the educational program, after 2 years. Body mass index z score is based on previous results, estimate that the BMI Z-score will be decreased by 0.3 +/- 0.6 SD.

Secondary Outcomes

  • Impact of rare pathogenic mutations causing obesity on changes in BMI Z-score.(Through study completion, an average of 3 years after inclusion)
  • BMI Z-score between children included in the study and a historical control group(At the end of the educational program, an average of 2 years after inclusion)
  • Changes in BMI Z-score.(At the end of the educational program follow-up, an average of 3 years after inclusion)
  • Impact of polygenic risk scores of obesity on changes in BMI Z-score(Through study completion, an average of 3 years after inclusion)
  • Correlation between clinical and environmental variables and changes in BMI Z-score(At the end of the educational program, an average of 2 years after inclusion)

Study Sites (2)

Loading locations...

Similar Trials